Corrigendum: Molecular targeting therapies for neuroblastoma: Progress and challenges
- PMID: 34250611
- PMCID: PMC9050082
- DOI: 10.1002/med.21843
Corrigendum: Molecular targeting therapies for neuroblastoma: Progress and challenges
Erratum for
-
Molecular targeting therapies for neuroblastoma: Progress and challenges.Med Res Rev. 2021 Mar;41(2):961-1021. doi: 10.1002/med.21750. Epub 2020 Nov 6. Med Res Rev. 2021. PMID: 33155698 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources